Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-58,754
Closed -$6.79M 169
2015
Q3
$6.79M Buy
58,754
+53,611
+1,042% +$6.02M 0.15% 87
2015
Q2
$535K Sell
5,143
-645
-11% -$69.6K 0.01% 252
2015
Q1
$639K Sell
5,788
-310
-5% -$33.7K 0.01% 285
2014
Q4
$636K Sell
6,098
-1,173
-16% -$117K 0.01% 275
2014
Q3
$698K Sell
7,271
-155
-2% -$14K 0.01% 301
2014
Q2
$678K Sell
7,426
-10
-0.1% -$896 0.03% 314
2014
Q1
$655K Sell
7,436
-10,603
-59% -$931K 0.03% 298
2013
Q4
$1.67M Buy
18,039
+1,515
+9% +$136K 0.04% 301
2013
Q3
$1.35M Buy
16,524
+4
+0% +$338 0.04% 330
2013
Q2
$1.37M Buy
+16,520
New +$1.42M 0.02% 412

Other funds holding CLX

NatWest Group's CLX Position: Q4 2015 in Review

NatWest Group sold out of Clorox (CLX) in Q4 2015, closing a stake of 58,754 shares — an estimated $6.79M sold.

NatWest Group first reported a position in CLX in Q2 2013 and held it in 10 quarters. The position peaked at $6.79M in Q3 2015. 830 funds tracked by Wall St. Rank hold CLX as of Q4 2015.

  • NatWest Group reported no remaining Clorox position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 58,754 Clorox shares in Q4 2015, an estimated $6.79M.
  • NatWest Group first reported a position in Clorox in Q2 2013 and held it in 10 quarters.
  • NatWest Group's Clorox position peaked at $6.79M in Q3 2015.
  • 830 funds tracked by Wall St. Rank held Clorox as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.